
Vasotop 30mg Tablet
Marketer
Cipla Ltd
Salt Composition
Nimodipine (30mg)
Overview Vasotop 30mg Tablet
CerebralGuard 30mg tablets are prescribed to manage and mitigate further brain injury following a subarachnoid hemorrhage (SAH). This calcium channel blocker enhances cerebral blood flow, reducing the risk of neurological impairment. Treatment with CerebralGuard 30mg tablets should commence as soon as a doctor confirms SAH. Dosage and frequency are determined individually by your physician, based on your health status and treatment response. Administration may be with or without food, but consistent adherence to the prescribed regimen is crucial for optimal results. Avoid antacids within two hours of ingestion, as this may compromise efficacy. Discontinuation requires prior consultation with your doctor; premature cessation could exacerbate your condition. Common adverse effects encompass hypotension, tachycardia, headache, gastrointestinal upset, nausea, rash, muscle spasms, and generalized edema. Report any persistent, worsening, or bothersome side effects to your doctor immediately. Prior to commencing CerebralGuard 30mg tablets, disclose any pre-existing cardiac or hepatic issues. Interactions may occur with certain medications, particularly anticonvulsants and antihypertensives or cardio-active drugs. Comprehensive disclosure of all current medications is essential for safety. Pregnant or lactating individuals should seek medical counsel before initiating treatment. Your doctor will monitor your blood pressure throughout the treatment period.
Uses of Vasotop 30mg Tablet
Bleeding into the subarachnoid space
Major Benefits of Vasotop 30mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 30mg Vasotop tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Vasotop 30mg Tablet:
- Decreased blood pressure
- Headache
- Increased heart rate
- Nausea
- Rash
- Stomach discomfort
- Edema (swelling)
- Muscle cramp
How to use Vasotop 30mg Tablet:
Follow your physician's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 30mg Vasotop tablet whole; avoid chewing, crushing, or fracturing it. This medication can be administered with or without food, however, consistent timing is recommended.
How Vasotop 30mg Tablet works:
Cerebrovascular-protective Vasotop 30mg tablets function as calcium channel blockers, promoting vasodilation within cerebral blood vessels to facilitate improved blood flow. This action mitigates the risk of brain injury resulting from intracranial hemorrhage.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Vasotop 30mg tablets and alcohol can result in significant sedation.
PregnancyCONSULT YOUR DOCTOR
The use of Vasotop 30mg Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Vasotop 30mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a 30mg Vasotop tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Employing Vasotop 30mg tablets in patients with kidney disease appears to present a low risk. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverCAUTION
Individuals with severe hepatic impairment should use Vasotop 30mg tablets cautiously. Dosage modification of Vasotop 30mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Vasotop 30mg Tablet :
NA
Facts to Know About Vasotop 30mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Dihydropyridine carboxylic acid derivatives |
| Developing Habits | No. |
| Type of Therapy | Heart |
| Actions | Dihydropyridine Calcium Channel Blockers |
